New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
New cancer therapy takes personalized medicine to a new level

New cancer therapy takes personalized medicine to a new level

by Karen WeintraubCredit: Unsplash/CC0 Public DomainPersonalized care has been a buzzword in medicine for years, but new research on cancer treatment is taking it to a new level.Detailed in a study pu
Oncology January 11,2024
New cancer therapy takes personalized medicine to a new level

New cancer therapy takes personalized medicine to a new level

by Karen WeintraubCredit: Unsplash/CC0 Public DomainPersonalized care has been a buzzword in medicine for years, but new research on cancer treatment is taking it to a new level.Detailed in a study pu
Oncology January 11,2024
New cancer 'tracer' promises to detect more tumors earlier

New cancer 'tracer' promises to detect more tumors earlier

by Ramona Czakert Franson,University of AlbertaCredit: Pixabay/CC0 Public DomainFor people waiting for imaging tests to diagnose neuroendocrine cancer, time is of the essence. Now, thanks to res
Oncology January 11,2024
New cancer 'tracer' promises to detect more tumors earlier

New cancer 'tracer' promises to detect more tumors earlier

by Ramona Czakert Franson,University of AlbertaCredit: Pixabay/CC0 Public DomainFor people waiting for imaging tests to diagnose neuroendocrine cancer, time is of the essence. Now, thanks to res
Oncology January 11,2024
New PET tracer shows promise for uPAR-targeted therapy of neuroendocrine neoplasms

New PET tracer shows promise for uPAR-targeted therapy of neuroendocrine neoplasms

by Society of Nuclear Medicine and Molecular ImagingGraphical abstract. Credit:Journal of Nuclear Medicine(2022). DOI: 10.2967/jnumed.121.263177A novel PET radiotracer can accurately asses
Oncology January 11,2024
New PET tracer shows promise for uPAR-targeted therapy of neuroendocrine neoplasms

New PET tracer shows promise for uPAR-targeted therapy of neuroendocrine neoplasms

by Society of Nuclear Medicine and Molecular ImagingGraphical abstract. Credit:Journal of Nuclear Medicine(2022). DOI: 10.2967/jnumed.121.263177A novel PET radiotracer can accurately asses
Oncology January 11,2024
New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

byKing's College LondonUCART19 cellular kinetics and correlation with clinical response. A, Graphical representation of UCART19 kinetic profile in PB of patients with B-ALL in the CALM study
Oncology January 11,2024
New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

byKing's College LondonUCART19 cellular kinetics and correlation with clinical response. A, Graphical representation of UCART19 kinetic profile in PB of patients with B-ALL in the CALM study
Oncology January 11,2024
New CAR T-cell therapy research shows potential in solid tumors

New CAR T-cell therapy research shows potential in solid tumors

by Peter MacCallum Cancer CenterCredit: Peter MacCallum Cancer CenterPeter Mac researchers have developed a new approach to chimeric antigen receptor (CAR) T-cell therapy which has proven effective in
Oncology January 11,2024
New CAR T-cell therapy research shows potential in solid tumors

New CAR T-cell therapy research shows potential in solid tumors

by Peter MacCallum Cancer CenterCredit: Peter MacCallum Cancer CenterPeter Mac researchers have developed a new approach to chimeric antigen receptor (CAR) T-cell therapy which has proven effective in
Oncology January 11,2024
New CAR T-cell strategy highly effective against small cell lung cancer in preclinical study

New CAR T-cell strategy highly effective against small cell lung cancer in preclinical study

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainA new approach to chimeric antigen receptor T-cell (CAR T) therapy has shown great promise against small cell lung cancer (S
Oncology January 11,2024
New CAR T-cell strategy highly effective against small cell lung cancer in preclinical study

New CAR T-cell strategy highly effective against small cell lung cancer in preclinical study

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainA new approach to chimeric antigen receptor T-cell (CAR T) therapy has shown great promise against small cell lung cancer (S
Oncology January 11,2024
Novel checklist for 'quality of life' to take cancer clinical trials to the next level

Novel checklist for 'quality of life' to take cancer clinical trials to the next level

byEuropean Society for Medical OncologyCredit:Annals of Oncology(2022). DOI: 10.1016/j.annonc.2022.12.004The European Society for Medical Oncology (ESMO) has developed a quality of l
Oncology January 11,2024
Novel checklist for 'quality of life' to take cancer clinical trials to the next level

Novel checklist for 'quality of life' to take cancer clinical trials to the next level

byEuropean Society for Medical OncologyCredit:Annals of Oncology(2022). DOI: 10.1016/j.annonc.2022.12.004The European Society for Medical Oncology (ESMO) has developed a quality of l
Oncology January 11,2024
New approach to 'punishment and reward' method of AI training offers potential for aggressive cancers

New approach to 'punishment and reward' method of AI training offers potential for aggressive cancers

byUniversity of SurreyCredit: Unsplash/CC0 Public DomainA new "outside-the-box" method of teaching artificial intelligence (AI) models to make decisions could provide hope for finding
Oncology January 11,2024
New approach to 'punishment and reward' method of AI training offers potential for aggressive cancers

New approach to 'punishment and reward' method of AI training offers potential for aggressive cancers

byUniversity of SurreyCredit: Unsplash/CC0 Public DomainA new "outside-the-box" method of teaching artificial intelligence (AI) models to make decisions could provide hope for finding
Oncology January 11,2024
New reports examine COVID's radiotherapy interruption implications

New reports examine COVID's radiotherapy interruption implications

by University of Tennessee Health Science Center(A-D) Major radiation therapy (RT) interruption rates before and during the pandemic mapped by ZIP code across the metropolitan region by race and insur
Oncology January 11,2024
New reports examine COVID's radiotherapy interruption implications

New reports examine COVID's radiotherapy interruption implications

by University of Tennessee Health Science Center(A-D) Major radiation therapy (RT) interruption rates before and during the pandemic mapped by ZIP code across the metropolitan region by race and insur
Oncology January 11,2024
New report finds smoking rates, alcohol use, physical inactivity decreased during COVID-19

New report finds smoking rates, alcohol use, physical inactivity decreased during COVID-19

byAmerican Cancer SocietyNew ACS Report. Credit: American Cancer SocietyIn a new report, American Cancer Society (ACS) researchers discovered both favorable and unfavorable changes in major canc
Oncology January 11,2024
New report finds smoking rates, alcohol use, physical inactivity decreased during COVID-19

New report finds smoking rates, alcohol use, physical inactivity decreased during COVID-19

byAmerican Cancer SocietyNew ACS Report. Credit: American Cancer SocietyIn a new report, American Cancer Society (ACS) researchers discovered both favorable and unfavorable changes in major canc
Oncology January 11,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com